CA9 and cancer: In conclusion, our results indicate that CA IX may be a suitable and specific biomarker for monitoring TNBC aggressiveness due to its involvement in helping cancer cells to adapt to the hostile hypoxic and acidic microenvironment through cell phenotype switching.